Compare Stocks

→ At first glance, this chart looks like nonsense… (From The TradingPub) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CMLF CM Life Sciences		$12.49	$9.66 ▼ $27.18	$641.99M	N/A	1.16 million shs	28,812 shs
FCAC Falcon Capital Acquisition	$0.77 +5.5%	$8.34	$8.85 ▼ $12.81	$33.30M	N/A	641,326 shs	2.37 million shs
HEC Hudson Executive Investment	$3.07 -2.2%	$8.58	$7.82 ▼ $12.45	$127.10M	N/A	1.42 million shs	660,275 shs
PNTG The Pennant Group	$20.71 -3.3%	$19.06	$10.31 ▼ $21.45	$621.51M	2.06	142,573 shs	231,376 shs
USPH U.S. Physical Therapy	$103.83 +0.4%	$104.84	$78.08 ▼ $124.11	$1.56B	1.39	70,176 shs	68,338 shs

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CMLF CM Life Sciences	0.00%	0.00%	0.00%	0.00%	0.00%
FCAC Falcon Capital Acquisition	+4.73%	+8.97%	-21.53%	-31.11%	-57.05%
HEC Hudson Executive Investment	+2.28%	+3.63%	-12.04%	+38.94%	+292.50%
PNTG The Pennant Group	+2.73%	+7.05%	+8.73%	+38.02%	+58.55%
USPH U.S. Physical Therapy	+3.58%	+4.20%	-6.46%	+10.16%	-2.73%

The system that called 2023’s top 7 stocks is at it again… (Ad)

Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.

Just follow this link here!

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CMLF CM Life Sciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCAC Falcon Capital Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
HEC Hudson Executive Investment	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PNTG The Pennant Group	2.2356 of 5 stars	1.3	4.0	0.0	0.0	1.8	2.5	3.1
USPH U.S. Physical Therapy	3.2354 of 5 stars	2.5	4.0	2.5	0.0	1.9	0.8	2.5

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CMLF CM Life Sciences	N/A	N/A	N/A	N/A
FCAC Falcon Capital Acquisition	N/A	N/A	N/A	N/A
HEC Hudson Executive Investment	N/A	N/A	N/A	N/A
PNTG The Pennant Group	2.67	Moderate Buy	$18.75	-9.46% Downside
USPH U.S. Physical Therapy	3.00	Buy	$125.67	21.03% Upside

Current Analyst Ratings

Latest USPH, PNTG, CMLF, FCAC, and HEC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/13/2024	USPH U.S. Physical Therapy	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$99.00 ➝ $117.00
3/1/2024	PNTG The Pennant Group	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$18.00 ➝ $22.00
3/1/2024	PNTG The Pennant Group	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$16.00 ➝ $21.00
3/1/2024	USPH U.S. Physical Therapy	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$120.00 ➝ $122.00

(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CMLF CM Life Sciences	N/A	N/A	N/A	N/A	$0.09 per share	N/A
FCAC Falcon Capital Acquisition	N/A	N/A	N/A	N/A	$0.12 per share	N/A
HEC Hudson Executive Investment	N/A	N/A	N/A	N/A	$0.12 per share	N/A
PNTG The Pennant Group	$544.89M	1.14	$0.78 per share	26.65	$4.86 per share	4.26
USPH U.S. Physical Therapy	$604.80M	2.59	$4.85 per share	21.43	$31.85 per share	3.26

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CMLF CM Life Sciences	-$39.91M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
FCAC Falcon Capital Acquisition	-$17.38M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
HEC Hudson Executive Investment	-$27.24M	N/A	0.00	∞	N/A	N/A	-337.48%	-4.06%	N/A
PNTG The Pennant Group	$13.38M	$0.44	47.07	24.08	2.20	2.46%	12.78%	3.36%	5/6/2024 (Confirmed)
USPH U.S. Physical Therapy	$28.24M	$1.35	76.91	33.93	4.74	4.67%	8.52%	3.92%	5/7/2024 (Confirmed)

Latest USPH, PNTG, CMLF, FCAC, and HEC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2024	N/A	USPH U.S. Physical Therapy	$0.58	N/A	-$0.58	N/A	N/A	N/A
5/6/2024	N/A	PNTG The Pennant Group	$0.15	N/A	-$0.15	N/A	N/A	N/A
2/28/2024	12/31/2023	PNTG The Pennant Group	$0.19	$0.18	-$0.01	$0.22	$136.79 million	$145.95 million
2/28/2024	Q4 2023	USPH U.S. Physical Therapy	$0.57	$0.59	+$0.02	$1.56	$150.24 million	$154.80 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CMLF CM Life Sciences	N/A	N/A	N/A	N/A	N/A
FCAC Falcon Capital Acquisition	N/A	N/A	N/A	N/A	N/A
HEC Hudson Executive Investment	N/A	N/A	N/A	N/A	N/A
PNTG The Pennant Group	N/A	N/A	N/A	N/A	N/A
USPH U.S. Physical Therapy	$1.76	1.70%	+75.17%	130.37%	5 Years

Latest USPH, PNTG, CMLF, FCAC, and HEC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/27/2024	USPH U.S. Physical Therapy	Quarterly	$0.44	1.65%	3/11/2024	3/12/2024	4/5/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CMLF CM Life Sciences	N/A	0.18	0.62
FCAC Falcon Capital Acquisition	N/A	2.75	2.75
HEC Hudson Executive Investment	N/A	0.33	0.33
PNTG The Pennant Group	0.44	1.12	1.12
USPH U.S. Physical Therapy	0.29	2.28	2.28

Ownership

Institutional Ownership

Company	Institutional Ownership
CMLF CM Life Sciences	49.83%
FCAC Falcon Capital Acquisition	61.70%
HEC Hudson Executive Investment	73.41%
PNTG The Pennant Group	85.88%
USPH U.S. Physical Therapy	N/A

Insider Ownership

Company	Insider Ownership
CMLF CM Life Sciences	N/A
FCAC Falcon Capital Acquisition	N/A
HEC Hudson Executive Investment	N/A
PNTG The Pennant Group	5.80%
USPH U.S. Physical Therapy	1.80%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CMLF CM Life Sciences	N/A	55.34 million	N/A	Optionable
FCAC Falcon Capital Acquisition	N/A	43.13 million	N/A	Not Optionable
HEC Hudson Executive Investment	N/A	41.40 million	N/A	Not Optionable
PNTG The Pennant Group	5,791	30.01 million	28.63 million	Optionable
USPH U.S. Physical Therapy	6,720	15.07 million	14.80 million	Optionable

USPH, PNTG, CMLF, FCAC, and HEC Headlines

Source	Headline
	U.S. Physical Therapy, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call businesswire.com - April 23 at 4:05 PM
	ADUS vs. USPH: Which Stock Is the Better Value Option? zacks.com - April 19 at 12:41 PM
	U.S. Physical Therapy (NYSE:USPH) Shares Pass Above 200 Day Moving Average of $95.00 americanbankingnews.com - April 19 at 3:22 AM
	Analysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), US Physical Therapy (USPH) markets.businessinsider.com - April 18 at 11:37 AM
	Personnel Physical Examination Policy Goes into Effect After 2nd Reading dresdenenterprise.com - April 12 at 6:08 PM
	Do I need therapy? A psychologist explains why some people might not wlrn.org - April 11 at 8:41 PM
	Calculating The Intrinsic Value Of U.S. Physical Therapy, Inc. (NYSE:USPH) finance.yahoo.com - April 10 at 1:28 PM
	U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Peregrine Capital Management LLC marketbeat.com - April 10 at 9:48 AM
	U.S. Physical Therapy, Inc. (NYSE:USPH) Given Average Recommendation of "Buy" by Analysts marketbeat.com - April 9 at 4:10 AM
	U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Purchased by Vanguard Group Inc. marketbeat.com - April 5 at 4:07 AM
	ADUS vs. USPH: Which Stock Should Value Investors Buy Now? zacks.com - April 3 at 12:46 PM
	USPh acquires 50% stake in physical therapy practice msn.com - April 2 at 5:07 PM
	UW Health introduces first respiratory therapy apprenticeship program msn.com - April 1 at 10:51 PM
	Mount St. Joseph has pro bono physical therapy clinic run by students local12.com - April 1 at 5:50 PM
	USPH Acquires 50% Stake In Nine Clinic Physical Therapy, Hand Therapy Practice For $16.4 Mln markets.businessinsider.com - April 1 at 8:53 AM
	U.S. Physical Therapy Announces Acquisition of a Nine-Clinic Physical Therapy And Hand Therapy Practice finance.yahoo.com - April 1 at 8:53 AM
	Copeland Capital Management LLC Sells 23,937 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) marketbeat.com - March 31 at 9:22 AM
	UW Health launches first registered Respiratory Therapy apprenticeship in the US wxow.com - March 29 at 5:40 PM
	New York State Association for Health, Physical Education, Recreation and Dance honors LI's top physical education students newsday.com - March 28 at 9:32 PM
	Physical: 100 Season 2 – Underground Episode 1: Contestants Participate In Gruesome Pre-Quest Mission yahoo.com - March 19 at 12:56 AM
	Nashville abandons physical ability test to hire more female police officers msn.com - March 19 at 12:56 AM
	Physical therapy improves patients’ lives, including that of former Miami Dolphin Jimmy Cefalo local10.com - March 19 at 12:56 AM
	ADUS or USPH: Which Is the Better Value Stock Right Now? zacks.com - March 18 at 12:46 PM
	Physical therapists in Gainesville practice unique non-invasive approach to treat endometriosis msn.com - March 16 at 4:23 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

CM Life Sciences

NASDAQ:CMLF

CM Life Sciences, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company focuses on targeting life science companies. CM Life Sciences, Inc. was incorporated in 2020 and is based in New York, New York.

Falcon Capital Acquisition

NASDAQ:FCAC

Falcon Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses. The company was incorporated in 2020 and is based in New York, New York.

Hudson Executive Investment

NASDAQ:HEC

Hudson Executive Investment Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

The Pennant Group

NASDAQ:PNTG

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

U.S. Physical Therapy

NYSE:USPH

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial